Max Gallant

Max Gallant has extensive experience in the biotechnology industry. Max began their career at MorNuCo, Inc. in 2016, where they held various roles including Flex-Lab Director, Director of Special Projects, and VP of Research. In 2017, they moved to Helio Genomics, where they served as the Director of Diagnostics before advancing to the role of Director of R&D, NGS.

Max Gallant holds a Bachelor's degree in Biochemistry from Université Laval. Max then pursued a Master's degree and a Doctor of Philosophy (PhD) in Immunology from Université de Sherbrooke.